Macquarie raises WeRide stock price target on robotaxi growth By Investing.com

Macquarie raised WeRide’s price target to $15.90 from $15.30 and kept an Outperform rating after Q1 sales rose 57% year-over-year to Rmb114 million, driven by higher service revenue. The company’s robotaxi fleet expanded to 1,300 units with gross margin steady at about 35%, though the non-GAAP net loss widened 11% to Rmb326 million and management does not expect profitability this year. WeRide also highlighted 2,000 GXR deliveries by end-2026, a larger overseas revenue mix in 2026, and an expanded Lenovo partnership targeting 200,000 autonomous vehicles over five years.

Analysis

WRD is transitioning from a pure “story stock” into a near-term execution trade: the key incremental signal is not revenue growth itself, but that utilization and gross margin are holding while the fleet scales. That combination implies operating leverage is starting to matter, and the market may be underappreciating how quickly a robotics platform can re-rate once customers see repeatable service economics rather than one-off pilot activity.

The second-order winner is likely the ecosystem around deployment, not just WRD itself. If overseas revenue rises toward a majority mix, the company becomes less exposed to domestic regulatory bottlenecks and more tied to jurisdictions where commercial approvals can convert faster into revenue; that shifts bargaining power toward overseas partners, fleet operators, and hardware integrators. The Lenovo tie-up also matters because it broadens distribution credibility, which can compress customer acquisition costs and potentially pull forward procurement decisions from municipalities and logistics operators that were previously waiting for a “winner.”

The main risk is that revenue quality remains too seasonal and too dependent on robotaxi rollouts to justify the current trajectory. A temporary pause in approvals can quickly become a multi-quarter delay if regulators use it to reassess safety standards, and Middle East recovery is the swing factor: one more geopolitical disruption would hit the business where the marginal growth is coming from. In other words, this is a months-long catalyst chain, not a days-long trade; if unit deliveries slip below expectations or overseas conversion stalls, the stock can de-rate sharply because losses are still widening.

Consensus seems focused on the top-line growth curve, but the more important question is whether the company can turn fleet expansion into a visible path to breakeven economics before capital markets lose patience. The current setup looks attractive only if overseas deployment continues to scale without a margin reset; otherwise the market may eventually treat WRD as a capital-intensive commercialization story rather than a platform winner. That creates an asymmetric setup: upside on continued execution is meaningful, but the downside if growth decelerates is large because profitability is not yet in sight.

Key Decisions for Investors

• Long WRD on a 3-6 month horizon with a staged entry on pullbacks toward prior support; target a re-rating toward the low-teens if overseas revenue mix expands and fleet utilization remains stable. Risk: a single quarter of delivery slippage or approvals delay can cut the multiple materially.
• Buy WRD call spreads expiring after the next two earnings prints to express upside from execution while capping premium outlay. Prefer structures that profit from a move into the $11-$15 range rather than outright calls given elevated business-model risk.
• Pair trade: long WRD / short a basket of slower-growth autonomous-vehicle peers with weaker international optionality, to isolate commercialization acceleration versus generic AI-autonomy hype. This is best held over 1-2 quarters as revenue mix shifts become visible.
• If exposed to the name already, use a trailing stop rather than a hard price target; the stock’s main risk is not valuation alone but headline-driven delays in licensing or overseas operations. Consider trimming on any sign that 2026 delivery guidance is pushed out.